Page last updated: 2024-11-08

sucrose-6-phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID644101
CHEBI ID131603
SCHEMBL ID134508
MeSH IDM0529441

Synonyms (18)

Synonym
sucrose 6-phosphate
6-phosphosucrose
6-o-phosphonosucrose
beta-d-fructofuranosyl-6-o-phosphono-alpha-d-glucopyranoside
sucrose-6-phosphate
22372-29-8
beta-d-fructofuranosyl 6-o-phosphono-alpha-d-glucopyranoside
alpha-d-glucopyranoside,beta-d-fructofuranosyl-6-(dihydrogen phosphate)
CHEBI:131603
71n414q30x ,
alpha-d-glucopyranoside, beta-d-fructofuranosyl-6-(dihydrogen phosphate)
unii-71n414q30x
SCHEMBL134508
hex-2-ulofuranosyl 6-o-phosphonohexopyranoside
DTXSID00945023
((2r,3s,4s,5r,6r)-6-(((2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)methyl dihydrogen phosphate
sucrose 6-phosphate (p on 6-ring)
Q27225216
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
disaccharide phosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Sucrose biosynthesis06

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (16.67)18.2507
2000's1 (8.33)29.6817
2010's8 (66.67)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.21 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.52 (4.65)
Search Engine Demand Index25.55 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]